Medical Decision Support to Reduce Unwarranted Methylene Tetrahydrofolate Reductase (MTHFR) Genetic Testing
- 31 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Medical Systems
- Vol. 44 (9), 1-6
- https://doi.org/10.1007/s10916-020-01615-5
Abstract
Most major national medical associations have advised against routine MTHFR testing since at least 2013. However, many providers continue to order this unwarranted genetic test. This study assessed the efficacy of an electronic best practice alert to aid ordering providers. We tracked the rate of MTHFR tests ordered per 1 million patients in the twelve months before and after the implementation of an alert that suggested an alternative test. Associated factors including the ordering department, diagnosis, patient sex, and patient age were also analyzed. Chi square analysis was used to compare the difference between pre- and post-alert test ordering rates. A total of 997 MTHFR analysis were ordered in Southern California Kaiser Permanente from January 2017 through December 2018. Overall, the average MTHFR monthly test ordering rates dropped significantly from 12.93 per million patients in 2017 to 7.08 per million patients in 2018 (p = 0.0056). However, testing rates in children were unchanged and, in some associated diagnoses, such as psychiatric illnesses and neurodevelopmental conditions, the testing rates increased. Recommending an alternate test in lieu of the unwarranted one significantly reduced the overall rate of MTHFR testing. The alert was most effective for specialties and diagnoses where MTHFR was historically medically indicated. This suggests such alerts are an effective intervention that health care systems can implement to serve as an educational update and to reduce unwarranted genetic testing.Keywords
This publication has 28 references indexed in Scilit:
- Practice Bulletin No. 138Obstetrics & Gynecology, 2013
- ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testingGenetics in Medicine, 2013
- Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication BiasPLoS Medicine, 2012
- Clinical Decision Support Systems Could Be Modified To Reduce ‘Alert Fatigue’ While Still Minimizing The Risk Of LitigationHealth Affairs, 2011
- Overriding of Drug Safety Alerts in Computerized Physician Order EntryJournal of the American Medical Informatics Association, 2006
- Homocysteine and MTHFR MutationsCirculation, 2005
- Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studiesJournal of Thrombosis and Haemostasis, 2005
- Ten Commandments for Effective Clinical Decision Support: Making the Practice of Evidence-based Medicine a RealityJournal of the American Medical Informatics Association, 2003
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyThe New England Journal of Medicine, 1999
- Automated Evidence-based Critiquing of Orders for Abdominal Radiographs: Impact on Utilization and AppropriatenessJournal of the American Medical Informatics Association, 1997